| Overall population (n = 413) | Diabetics (n = 210) | Non-diabetics (n = 203) | p Value* |
---|---|---|---|---|
Patients | ||||
Absence of CAD (%) | 134 (32) | 59 (28) | 75 (37) | 0.07 |
Non-obstructive CAD (%) | 169 (41) | 76 (36) | 93 (46) | 0.06 |
Obstructive CAD (%) | 110 (27) | 75 (36) | 35 (17) | <0.0001 |
Obstructive CAD in: | ||||
LM/LAD | 76 (18) | 54 (26) | 22 (11) | <0.001 |
RCA | 43 (10) | 32 (15) | 11 (5) | 0.001 |
CXA | 37 (9) | 25 (12) | 12 (6) | 0.05 |
Single-vessel disease (%) | 72 (17) | 46 (22) | 26 (13) | 0.02 |
Multivessel disease (%) | 38 (9) | 29 (14) | 9 (4) | 0.002 |
Total Agatston score | 250.7 (599.7) | 351.6 (743.4) | 146.2 (374.5) | <0.001 |
CACS ≤100 | 277 (67) | 132 (63) | 145 (71) | 0.08 |
CACS >100 | 136 (33) | 78 (37) | 58 (29) | 0.08 |
CACS >400 | 73 (18) | 50 (24) | 23 (11) | 0.001 |
Segments | ||||
No. of diseased segments | 3.7 (4.2) | 4.5 (4.6) | 2.8 (3.5) | <0.0001 |
No. of segments with | ||||
Non-obstructive plaque | 3.1 (3.7) | 3.7 (4.0) | 2.5 (3.2) | <0.001 |
Obstructive plaque | 0.6 (1.4) | 0.9 (1.8) | 0.3 (0.8) | <0.0001 |